News Daily News Two New Scores Help Hone 10-Year CV Death Risk in ASCVD Patients Caitlin E. Cox October 16, 2025
News Daily News Better Outcomes and Lower Cost with Bariatric Surgery Over GLP-1s Michael O'Riordan September 18, 2025
News Daily News Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data L.A. McKeown July 24, 2025
News Daily News Access to GLP-1 Drugs Unequal for US Patients With Obesity Caitlin E. Cox May 01, 2025
News Daily News Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE Caitlin E. Cox April 23, 2025
News Daily News Study Validates Accuracy of PREVENT for CVD Mortality Risk Prediction Todd Neale October 15, 2024
News Daily News Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes Michael O'Riordan August 19, 2024
News Daily News Obstacles Abound for Treating Severe BP: Some Clues for Care Lie in EHRs Caitlin E. Cox August 08, 2024
News Daily News Statins Effective For Primary Prevention in Old and Very Old Michael O'Riordan May 29, 2024
News Daily News Data Fail to Support Link Between COVID-19 Vaccines and SCD in Young People Todd Neale April 19, 2024
News Daily News EMA: No Evidence of Link Between GLP-1 Receptor Agonists and Suicidal Thoughts Todd Neale April 12, 2024
News Daily News FDA: No Signs of Link Between GLP-1s and Suicidal Thoughts, Actions Todd Neale January 12, 2024
News Daily News Most Takotsubo Patients Die From CV Causes, but Standard Meds No Help Todd Neale January 11, 2024
News Daily News European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba Michael O'Riordan September 15, 2023